Related Experiment Video
Updated: Jun 9, 2026
Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research
Published on: September 6, 2024
Differential responses of human microglia and blood-derived myeloid cells to FTY720
Bryce A Durafourt1, Caroline Lambert, Trina A Johnson
1Neuroimmunology Unit, Montréal Neurological Institute, McGill University, Montréal, Québec, Canada.
Abstract:
Human microglia, monocyte-derived dendritic cells (DCs) and macrophages ex vivo express relatively higher levels of sphingosine-1-phosphate (S1P) receptor 1 (S1P1) mRNA as compared to other receptor subtypes. The S1P agonist FTY720 decreased ERK phosphorylation and induced myosin light chain (MLC) II phosphorylation only in macrophages and DCs. FTY720 inhibited IL-12p70 production (CD40L induced) by DCs and macrophages but not microglia (poly I:C induced). IL-10 production was increased in DCs and unaffected in other myeloid cells. Despite similar receptor expression patterns, the distinct myeloid cell populations present in the human CNS, under steady-state or inflammatory conditions, exhibit differential responses to FTY720.
Insights
Human myeloid cells like macrophages and dendritic cells (DCs) respond differently to the S1P agonist FTY720, impacting immune signaling and cytokine production in the central nervous system (CNS).
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Sphingosine-1-phosphate (S1P) signaling plays a crucial role in regulating immune cell function.
- Receptor expression patterns can influence cellular responses to S1P agonists.
- Understanding differential myeloid cell responses in the central nervous system (CNS) is vital for neuroinflammatory research.
Purpose of the Study:
- To investigate the differential effects of the S1P agonist FTY720 on human microglia, dendritic cells (DCs), and macrophages.
- To analyze FTY720-induced changes in ERK and MLC II phosphorylation, and cytokine production (IL-12p70, IL-10) in these myeloid populations.
Main Methods:
- Ex vivo analysis of human myeloid cells (microglia, DCs, macrophages).
- Assessment of sphingosine-1-phosphate receptor 1 (S1P1) mRNA expression.
- Treatment with the S1P agonist FTY720 to evaluate effects on ERK and MLC II phosphorylation, and cytokine production.
Main Results:
- Human microglia, DCs, and macrophages express higher levels of S1P1 mRNA.
- FTY720 decreased ERK phosphorylation and induced MLC II phosphorylation in macrophages and DCs, but not microglia.
- FTY720 inhibited IL-12p70 production in DCs and macrophages, increased IL-10 in DCs, and had no effect on microglia cytokine production.
Conclusions:
- Despite similar S1P1 mRNA expression, distinct human myeloid cell populations in the CNS exhibit differential responses to FTY720.
- These findings highlight cell-specific signaling pathways and functional outcomes in response to S1P modulation within the CNS.
- Differential responses underscore the complexity of targeting S1P pathways for therapeutic interventions in neuroinflammatory conditions.
